ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0993

Successful Implementation of a New Patient Video Triage Program

Dr Tarun Sharma1, Adam Dore2, Caitlin Rossi3 and Jessica Heintzinger3, 1West Penn Hospital, New Delhi, India, 2Allegheny Health Network, Pittsburgh, PA, 3AHN, Pittsburgh, PA

Meeting: ACR Convergence 2023

Keywords: Access to care, Work Force

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 13, 2023

Title: (0993–1012) Health Services Research Poster II

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Many factors contribute to long wait times for new patient rheumatology visits including the increasing number of rheumatology referrals and new patient visits. Through a separate retrospective analysis, we found that many new patients (32%) in our rheumatology clinics likely did not need to see rheumatology and could have been evaluated via e-Consult (72%). In addition, with the expansion and acceptance of telemedicine, we postulated a new patient video triage program could facilitate appropriate care while also avoiding unnecessary in-person rheumatology appointments.

Methods: New patients scheduling a rheumatology appointment from December 2022 through May 2023 were offered a video triage appointment option with a rheumatology provider at our tertiary academic medical center. Patients were advised this appointment would determine whether they would need subsequent evaluation or follow-up with rheumatology. If appropriate after evaluation, they were scheduled for an in-person appointment (average of 2 weeks later). Subsequently, a chart review was completed to validate our primary outcome of interest: need of in-person rheumatology follow-up. We also compared the 2 groups of patients: those that needed in-person rheumatology follow up vs. those that did not need follow-up to evaluate for differences in terms of visit reason and referral source. Lastly, we measured the difference in median wait times for video vs in-person new appointments.

Results: A total of 225 patients were included in the rheumatology new patient video triage program. Of these, 103 (46%) patients were found to not require an in-person rheumatology follow up and were referred back to their primary care provider or another specialty for follow-up. Only 57 (25%) patients required a subsequent in-person rheumatology follow up. A total of 26 (12%) patients did not show to or cancelled their appointments. 14 (6%) patients did not complete follow-up testing after the video appointment. The remaining 25 patients are currently being assessed to determine if ongoing rheumatology care is needed. Referral sources were similar between patients who required rheumatology follow-up and those who did not (Table 1). Reasons for initial visit are shown in Table 1. The top diagnoses that did require rheumatology follow-up were joint pain, rheumatoid arthritis (RA), and +ANA, whereas those that did not require an in-person follow-up were joint pain, +ANA, and fibromyalgia. The current median wait for a new in-person rheumatology appointment in our division is 80 days compared to a 30 day wait time for a new patient video triage appointment.

Conclusion: Through a new patient video triage program for rheumatology patients, we have shown that only 25% of the video patients needed a subsequent in-person rheumatology follow up. The referral sources and most common reason for visit were similar between the 2 groups. Of note, the average wait time for a video triage appointment is less than half of an in-person new patient appointment. Given these findings, we plan to continue this successful new patient video program to help facilitate more timely initial rheumatology evaluation and facilitate more appropriate in-person rheumatology visits.

Supporting image 1

Table 1: Comparison of referral reason and referral source between rheumatology follow-up needed vs not needed groups


Disclosures: D. Sharma: None; A. Dore: AbbVie/Abbott, 1, 6, Bristol-Myers Squibb(BMS), 1, Exagen, 6, Novartis, 1; C. Rossi: None; J. Heintzinger: None.

To cite this abstract in AMA style:

Sharma D, Dore A, Rossi C, Heintzinger J. Successful Implementation of a New Patient Video Triage Program [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/successful-implementation-of-a-new-patient-video-triage-program/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/successful-implementation-of-a-new-patient-video-triage-program/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology